⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28168552 | 0.97 | TDP1 (0.50) | — | |
| SCHEMBL11050266 | 0.97 | TDP1 (0.50) | — | |
| SCHEMBL4235227 | 0.97 | TDP1 (0.50) | — | |
| SCHEMBL1310407 | 0.97 | TDP1 (0.50) | — | |
| SCHEMBL6253901 | 0.97 | TDP1 (0.50) | — | |
| SCHEMBL6253782 | 0.97 | TDP1 (0.50) | — | |
| SCHEMBL445647 | 0.97 | TDP1 (0.50) | — | |
| SCHEMBL6253810 | 0.97 | TDP1 (0.50) | — | |
| SCHEMBL629320 | 0.92 | — | — | |
| Hydrochloric Acid SCHEMBL4333850 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 355 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1456311-B1 | URETHANE POLYMERS THAT REDUCE THE EFFECT OF POLYLACTONE LINKAGES | BASF COATINGS GMBH (DE) | 2012-09-26 | — | — | EP | claimed |
| EP-1794203-B1 | FUNCTIONAL ADDITION POLYMERS AND A METHOD FOR THEIR PREPARATION | BASF CORP (US) | 2011-06-08 | — | — | EP | claimed |
| EP-1456310-B1 | ASYMMETRIC DIISOCYANATE MONOMERS IN URETHANE POLYMERS AND OLIGOMERS TO REDUCE CRYSTALLINITY | BASF CORP (US) | 2008-02-27 | — | — | EP | claimed |
| EP-1453921-B1 | CLEARCOAT COMPOSITION | BASF CORP (US) | 2007-05-09 | — | — | EP | claimed |
| EP-1266900-A1 | Carbamates of rapamycin | Wyeth (US) | 2002-12-18 | — | — | EP | claimed |
| CN-1091135-A | The carbamate of Wyeth-Ayerst Laboratories | AMERICAN HOME PROD (US) | 1994-08-24 | — | — | CN | claimed |
| EP-0593227-A1 | Carbamates of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1994-04-20 | — | — | EP | claimed |
| US-5302584-A | Immunosuppressants | AMERICAN HOME PRODUCTS CORPORATION (US) | 1994-04-12 | — | — | US | claimed |
| WO-2024097948-A1 | DEGRADERS OF MDM2 AND USES THEREOF | ROIVANT DISCOVERY, INC. (US) | 2024-05-10 | — | — | WO | disclosed |
| US-20240115711-A1 | Novel Bifunctional Molecules For Targeted Protein Degradation | AMPHISTA THERAPEUTICS LIMITED (GB) | 2024-04-11 | — | — | US | disclosed |
| WO-2024065043-A1 | AMINO ACID-CONTAINING IONIZABLE LIPIDS FOR THE DELIVERY OF THERAPEUTIC AGENTS | NANOVATION THERAPEUTICS INC. (CA) | 2024-04-04 | — | — | WO | disclosed |
| US-20240110015-A1 | SUPRAMOLECULAR BIOMEDICAL POLYMERS | SUPRAPOLIX B.V. (NL) | 2024-04-04 | — | — | US | disclosed |
| WO-2024059808-A1 | WEE1 INHIBITORS AND METHODS FOR TREATING CANCER | RECURIUM IP HOLDINGS, LLC (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2024052701-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |
| CN-1143075-A | 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics | FOURNIER IND & SANTE (FR) | 1997-02-19 | — | — | CN | disclosed |
| US-5411967-A | Antiinflammatory, immunosuppressant, antitumor | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-05-02 | — | — | US | disclosed |
| EP-0593227-A1 | Carbamates of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1994-04-20 | — | — | EP | disclosed |
| US-5302584-A | Immunosuppressants | AMERICAN HOME PRODUCTS CORPORATION (US) | 1994-04-12 | — | — | US | disclosed |
| EP-0207461-A2 | Process for the preparation of omega-isocyanatoalkyl(meth)acrylates | BASF Aktiengesellschaft (DE) | 1987-01-07 | — | — | EP | disclosed |
| US-4331438-A | TREATMENT WITH A FORMALDEHYDE ACCEPTOR | BASF WYANDOTTE CORPORATION (US) | 1982-05-25 | — | — | US | disclosed |